Pancreatic Cancer Research

ResearcherNational Institute of Biomedical Innovation, Health and NutritionActive in the last 2 years

Hirotomo Murakami

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0734-4298; OpenAlex author ID A5033590676. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

  1. Circulating tumor-associated antigen-specific IFNγ+4-1BB+ CD8+ T cells as peripheral biomarkers of treatment outcomes in patients with pancreatic cancer. Co-author DOI 10.3389/fimmu.2024.1363568↗
  2. The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer. First author DOI 10.3892/or.2023.8535↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masaya Higashiguchi · 2 shared papers, 2023–2024 · strength 0.35
  2. Yuichiro Doki · 2 shared papers, 2023–2024 · strength 0.35
  3. Hidetoshi Eguchi · 2 shared papers, 2023–2024 · strength 0.35
  4. Takuya Yamamoto · 2 shared papers, 2023–2024 · strength 0.35
  5. Hirofumi Akita · 1 shared paper, 2024 · strength 0.18
  6. Hidenori Takahashi · 1 shared paper, 2024 · strength 0.18
  7. Yoshifumi Iwagami · 1 shared paper, 2023 · strength 0.16
  8. Yoshito Tomimaru · 1 shared paper, 2023 · strength 0.16
  9. Daisaku Yamada · 1 shared paper, 2023 · strength 0.16
  10. Kunihito Gotoh · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.